- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05819619
Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days
Study Overview
Status
Study Type
Enrollment (Estimated)
Phase
- Early Phase 1
Contacts and Locations
Study Contact
- Name: Antonia Oladipo, MD
- Phone Number: 5519962765
- Email: antonia.oladipo@hmhn.org
Study Locations
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Recruiting
- Antonia Oladipo
-
Contact:
- Antonia Oladipo
- Phone Number: 551-996-2765
- Email: antonia.oladipo@hmhn.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy
- English speaking
- female volunteers undergoing medical abortion whether for voluntary interruption of pregnancy or missed abortion
- Gestational age </= 70 days confirmed via ultrasound
- Access to a time keeping device
- Willingness to complete a telephone or in-clinic follow up
Exclusion Criteria:
- chronic medical problems including but not limited to cardiac conditions, malignancy or organ damage
- Failed medical abortion resulting in surgical management
- Known intrauterine infection
- Known allergy to ondansetron or ibuprofen
- Subjects chronically receiving analgesic drugs
- Subjects unable to give consent
- Subjects taking medications that interact with ondansetron or ibuprofen
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard of care
Administration of ibuprofen or ondansetron only when experiencing pain or nausea respectively post misoprostol administration.
|
Administration of ibuprofen or ondansetron only when experiencing pain or nausea respectively post misoprostol administration.
|
Experimental: Prophylactic use
Administration of ibuprofen and ondansetron at the time of misoprostol administration.
|
Prophylactic use of ibuprofen and ondansetron post misoprostol administration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: At follow up visit, within 2 weeks from the administration of misoprostol
|
Determine if prophylactic use of ondansetron and ibuprofen during medical abortion treatment can increase patient satisfaction thereby creating a more favorable outcome. Patient satisfaction will be assessed using a home developed survey. Satisfaction is measured on 5-Likert scale ranging from Very satisfied to Very dissatisfied. |
At follow up visit, within 2 weeks from the administration of misoprostol
|
Patient satisfaction based on recommendation of regimen
Time Frame: At follow up visit, within 2 weeks from the administration of misoprostol
|
Determine if prophylactic use of ondansetron and ibuprofen during medical abortion treatment can increase patient satisfaction based on their likelihood to recommend the regimen. Likelihood to recommend will be assessed using a home developed survey measured on 5-Likert scale ranging from "Extremely likely to recommend" to "Extremely unlikely to recommend" (an additional "I do not know option" will be provided). |
At follow up visit, within 2 weeks from the administration of misoprostol
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain management at 6-8 hours
Time Frame: Within 6-8 hours from the administration of misoprostol
|
Evaluate for a satisfactory pain management regimen for medical abortion using a numerical pain scale ranging from 1 to 10 with 1 being "no pain" and 10 being "very much pain".
|
Within 6-8 hours from the administration of misoprostol
|
Pain management at 24 hours
Time Frame: Within 24 hours from the administration of misoprostol
|
Evaluate for a satisfactory pain management regimen for medical abortion using a numerical pain scale ranging from 1 to 10 with 1 being "no pain" and 10 being "very much pain".
|
Within 24 hours from the administration of misoprostol
|
Nausea Management
Time Frame: Within 6-8 hours from the administration of misoprostol
|
Evaluate for a satisfactory anti-nausea management regimen for medical abortion using a numerical nausea scale ranging from 1 to 10 with 1 being "no nausea" and 10 being "very much nausea".
|
Within 6-8 hours from the administration of misoprostol
|
Nausea Management
Time Frame: Within 24 hours from the administration of misoprostol
|
Evaluate for a satisfactory anti-nausea management regimen for medical abortion using a numerical nausea scale ranging from 1 to 10 with 1 being "no nausea" and 10 being "very much nausea".
|
Within 24 hours from the administration of misoprostol
|
Need for pain management medication.
Time Frame: Within 24 hours from the administration of misoprostol
|
Evaluate for a satisfactory pain management regimen for medical abortion based on the need for additional pain medication (Yes vs. No).
|
Within 24 hours from the administration of misoprostol
|
Need for anti-nausea medication.
Time Frame: Within 24 hours from the administration of misoprostol
|
Evaluate for a satisfactory anti-nausea management regimen for medical abortion based on the additional anti-nausea medication (Yes vs. No).
|
Within 24 hours from the administration of misoprostol
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Melissa Figueroa, MD, Hackensack Meridian Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Signs and Symptoms, Digestive
- Nausea
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Antiemetics
- Gastrointestinal Agents
- Dermatologic Agents
- Serotonin Agents
- Serotonin Antagonists
- Serotonin 5-HT3 Receptor Antagonists
- Reproductive Control Agents
- Anti-Ulcer Agents
- Antipruritics
- Abortifacient Agents, Nonsteroidal
- Abortifacient Agents
- Oxytocics
- Misoprostol
- Ibuprofen
- Ondansetron
Other Study ID Numbers
- Pro2021-1405
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
Clinical Trials on Use of ibuprofen and ondansetron at symptom onset post misoprostol administration
-
Washington University School of MedicineTerminatedOpioid Use | Pain, ChronicUnited States